Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol

Method development for a translational research study

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: Norepinephrine (NE), a sympathetic neurotransmitter, is often measured in plasma as an index of sympathetic activity. To better understand NE dynamics, it is important to measure its principal metabolite, 3,4-dihydroxyphenylglycol (DHPG), concurrently. Our aim was to present a method, developed in the course of a translational research study, to measure NE and DHPG in human plasma using high performance liquid chromatography with electrochemical detection (HPLC-ED). Results: After pre-purifying plasma samples by alumina extraction, we used HPLC-ED to separate and quantify NE and DHPG. In order to remove uric acid, which co-eluted with DHPG, a sodium bicarbonate wash was added to the alumina extraction procedure, and we oxidized the column eluates followed by reduction because catechols are reversibly oxidized whereas uric acid is irreversibly oxidized. Average recoveries of plasma NE and DHPG were 35.3 ± 1.0% and 16.3 ± 1.1%, respectively, and there was no detectable uric acid. Our estimated detection limits for NE and DHPG were approximately 85 pg/mL (0.5 pmol/mL) and 165 pg/mL (0.9 pmol/mL), respectively. The measurement of NE and DHPG in human plasma has wide applicability; thus, we describe a method to quantify plasma NE and DHPG in a laboratory setting as a useful tool for translational and clinical research.

Original languageEnglish (US)
Article number248
JournalBMC Research Notes
Volume11
Issue number1
DOIs
StatePublished - Apr 19 2018

Fingerprint

Translational Medical Research
Norepinephrine
Plasmas
Uric Acid
Plasma (human)
Aluminum Oxide
High performance liquid chromatography
High Pressure Liquid Chromatography
Catechols
Sodium Bicarbonate
dihydroxyphenylethylene glycol
Metabolites
Neurotransmitter Agents
Limit of Detection
Recovery

Keywords

  • 3 4-dihydroxyphenylglycol
  • Electrochemical detection
  • High performance liquid chromatography
  • Human plasma
  • Norepinephrine
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{ff16d6a65a804bd58e536b8c9c3f038e,
title = "Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol: Method development for a translational research study",
abstract = "Objective: Norepinephrine (NE), a sympathetic neurotransmitter, is often measured in plasma as an index of sympathetic activity. To better understand NE dynamics, it is important to measure its principal metabolite, 3,4-dihydroxyphenylglycol (DHPG), concurrently. Our aim was to present a method, developed in the course of a translational research study, to measure NE and DHPG in human plasma using high performance liquid chromatography with electrochemical detection (HPLC-ED). Results: After pre-purifying plasma samples by alumina extraction, we used HPLC-ED to separate and quantify NE and DHPG. In order to remove uric acid, which co-eluted with DHPG, a sodium bicarbonate wash was added to the alumina extraction procedure, and we oxidized the column eluates followed by reduction because catechols are reversibly oxidized whereas uric acid is irreversibly oxidized. Average recoveries of plasma NE and DHPG were 35.3 ± 1.0{\%} and 16.3 ± 1.1{\%}, respectively, and there was no detectable uric acid. Our estimated detection limits for NE and DHPG were approximately 85 pg/mL (0.5 pmol/mL) and 165 pg/mL (0.9 pmol/mL), respectively. The measurement of NE and DHPG in human plasma has wide applicability; thus, we describe a method to quantify plasma NE and DHPG in a laboratory setting as a useful tool for translational and clinical research.",
keywords = "3 4-dihydroxyphenylglycol, Electrochemical detection, High performance liquid chromatography, Human plasma, Norepinephrine, Sympathetic nervous system",
author = "Quin Denfeld and Beth Habecker and William Woodward",
year = "2018",
month = "4",
day = "19",
doi = "10.1186/s13104-018-3352-3",
language = "English (US)",
volume = "11",
journal = "BMC Research Notes",
issn = "1756-0500",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol

T2 - Method development for a translational research study

AU - Denfeld, Quin

AU - Habecker, Beth

AU - Woodward, William

PY - 2018/4/19

Y1 - 2018/4/19

N2 - Objective: Norepinephrine (NE), a sympathetic neurotransmitter, is often measured in plasma as an index of sympathetic activity. To better understand NE dynamics, it is important to measure its principal metabolite, 3,4-dihydroxyphenylglycol (DHPG), concurrently. Our aim was to present a method, developed in the course of a translational research study, to measure NE and DHPG in human plasma using high performance liquid chromatography with electrochemical detection (HPLC-ED). Results: After pre-purifying plasma samples by alumina extraction, we used HPLC-ED to separate and quantify NE and DHPG. In order to remove uric acid, which co-eluted with DHPG, a sodium bicarbonate wash was added to the alumina extraction procedure, and we oxidized the column eluates followed by reduction because catechols are reversibly oxidized whereas uric acid is irreversibly oxidized. Average recoveries of plasma NE and DHPG were 35.3 ± 1.0% and 16.3 ± 1.1%, respectively, and there was no detectable uric acid. Our estimated detection limits for NE and DHPG were approximately 85 pg/mL (0.5 pmol/mL) and 165 pg/mL (0.9 pmol/mL), respectively. The measurement of NE and DHPG in human plasma has wide applicability; thus, we describe a method to quantify plasma NE and DHPG in a laboratory setting as a useful tool for translational and clinical research.

AB - Objective: Norepinephrine (NE), a sympathetic neurotransmitter, is often measured in plasma as an index of sympathetic activity. To better understand NE dynamics, it is important to measure its principal metabolite, 3,4-dihydroxyphenylglycol (DHPG), concurrently. Our aim was to present a method, developed in the course of a translational research study, to measure NE and DHPG in human plasma using high performance liquid chromatography with electrochemical detection (HPLC-ED). Results: After pre-purifying plasma samples by alumina extraction, we used HPLC-ED to separate and quantify NE and DHPG. In order to remove uric acid, which co-eluted with DHPG, a sodium bicarbonate wash was added to the alumina extraction procedure, and we oxidized the column eluates followed by reduction because catechols are reversibly oxidized whereas uric acid is irreversibly oxidized. Average recoveries of plasma NE and DHPG were 35.3 ± 1.0% and 16.3 ± 1.1%, respectively, and there was no detectable uric acid. Our estimated detection limits for NE and DHPG were approximately 85 pg/mL (0.5 pmol/mL) and 165 pg/mL (0.9 pmol/mL), respectively. The measurement of NE and DHPG in human plasma has wide applicability; thus, we describe a method to quantify plasma NE and DHPG in a laboratory setting as a useful tool for translational and clinical research.

KW - 3 4-dihydroxyphenylglycol

KW - Electrochemical detection

KW - High performance liquid chromatography

KW - Human plasma

KW - Norepinephrine

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=85045637515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045637515&partnerID=8YFLogxK

U2 - 10.1186/s13104-018-3352-3

DO - 10.1186/s13104-018-3352-3

M3 - Article

VL - 11

JO - BMC Research Notes

JF - BMC Research Notes

SN - 1756-0500

IS - 1

M1 - 248

ER -